NEXGEL, INC. Noncash or Part Noncash Acquisition, Intangible Assets Acquired
NEXGEL, INC. (NXGL) reported Noncash or Part Noncash Acquisition, Intangible Assets Acquired of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-21.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 · last filed 2022-03-21
- NEXGEL, INC. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2021-12-31 was $0.00.
- NEXGEL, INC. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2021-09-30 was $0.00.
- NEXGEL, INC. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2020-12-31 was $0.00.
- NEXGEL, INC. noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2020-09-30 was $0.00.
- NEXGEL, INC. noncash or part noncash acquisition, intangible assets acquired for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- NEXGEL, INC. noncash or part noncash acquisition, intangible assets acquired for fiscal 2020 was $21.00K.
- NEXGEL, INC. noncash or part noncash acquisition, intangible assets acquired for fiscal 2019 was $0.00.
| Period end | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 12 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $0.00 derived: sum of 2 quarters · filed 2022-03-21 | $0.00 10-K · filed 2022-03-21 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $0.00 derived: sum of 2 quarters · filed 2022-03-21 | $21.00K 10-K · filed 2022-03-21 | $55.00K 10-K · filed 2021-03-31 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $21.00K 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $21.00K 10-Q · filed 2021-08-16 | ||||
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |